X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/bitbiome-and-kaken-pharmaceuticals-sign-joint-research-agreement-on-the-discovery-of-drugs-for-infectious-diseases-301781763.html
https://www.globenewswire.com/news-release/2023/01/08/2584735/37067/en/CymaBay-Therapeutics-Announces-Collaboration-with-Kaken-Pharmaceutical-Co-Ltd-to-Develop-and-Commercialize-Seladelpar-in-Japan-for-Primary-Biliary-Cholangitis.html
https://www.globenewswire.com/news-release/2021/06/24/2252547/0/en/Brickell-Biotech-Announces-Initiation-of-a-Phase-1-Study-of-Sofpironium-Bromide-Gel-in-Primary-Palmoplantar-Hyperhidrosis-Patients-by-its-Development-Partner-Kaken-Pharmaceutical-i.html
https://www.numab.com/wp-content/uploads/2021/01/210113_PR_Numab_Kaken_EN_update.pdf
https://seekingalpha.com/pr/18020127-brickell-biotech-announces-approval-of-sofpironium-bromide-gel-5-in-japan-for-treatment-of
https://www.biospace.com/article/releases/brickell-biotech-announces-issuance-of-new-composition-of-matter-patent-on-sofpironium-bromide-by-the-japanese-patent-office/
https://www.globenewswire.com/news-release/2020/01/10/1969125/0/en/Brickell-Bio-s-Development-Partner-Kaken-Pharmaceutical-Submits-New-Drug-Application-for-Sofpironium-Bromide-in-Japan-for-Primary-Axillary-Hyperhidrosis.html
Market Place
Share 
